drugset / Trial / NCT07560332

Oral Propranolol Versus Fractional Carbon Dioxide CO2 Laser Assisted Delivery of Topical Timolol for Treatment of Infantile Hemangioma

NCT07560332

Completed 30 enrolled Cairo University
RandomizedParallel-groupOpen-labelTreatment

Summary

To assess and compare the efficacy of systemic beta-blocker therapy with the efficacy and safety of fractional carbon dioxide laser-assisted delivery of a topical beta-blocker solution in the treatment of infantile hemangioma.

Timeline

Start
2025-01-01
Primary completion
2026-01-01
Completion
2026-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propranolol Small molecule 1 mg/kg Oral
Comparator Propranolol Small molecule 2 mg/kg Oral

Indications